Read more at CNBC.
Eli Lilly's top-selling drug last year is softening. But it may not matter for the stock
Date: |
Sort by
Filter
Date
Items per page
-
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
CNBC's Jim Cramer on Friday walked investors through next week on Wall Street.CNBC - Business - Federal Reserve -
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may helpABC News - World -
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may helpABC News - Health -
Cost of developing new drugs may be far lower than industry claims, trial reveals
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies. Doctors have for the first time released details of their spending on a major clinical trial, ...The Guardian - World -
A US citizen facing drug charges in Russia appears in court. His case was adjourned until mid-May
A U.S. citizen arrested on drug charges in Moscow amid soaring Russia-U.S. tensions has appeared in court and had his case adjourned until mid-MayABC News - World -
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may helpABC News - Health -
The timing may be just right to buy Nvidia or other semiconductor stocks
So far this year, the PHLX Semiconductor Index has increased 8.7% (with dividends reinvested), but it has declined 7.7% in April. Meanwhile, shares of industry star Nvidia Inc. have declined 12% this month.MarketWatch - Business -
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
AbbVie on Friday reported first-quarter results that beat expectations even as sales of its blockbuster autoimmune drug Humira continued to fall.MarketWatch - Business -
1994 Was the Last Good Year—and It's Still Going
Nine Inch Nails, Pulp Fiction, “Regulate.” The last year before culture began to migrate online was not like any other.Wired - Tech -
1994 Was the Last Good Year—and It's Still Going
Nine Inch Nails, Pulp Fiction, “Regulate.” The last year before culture began to migrate online was not like any other.Wired - Tech
More from CNBC
-
Morgan Stanley banker sees 10 to 15 more tech IPOs in 2024, and a 'better year' in 2025
Morgan Stanley, which led the Reddit and Astera Labs IPOs, expects 10 to 15 more tech offerings this year and a "better year" in 2025.CNBC - Business -
Biden administration faces onslaught of lawsuits as business groups claim regulatory overreach
The Biden administration faces a wave of lawsuits targeting its regulatory agenda, as business groups argue federal agencies are overstepping their authority.CNBC - Business - Joe Biden -
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.CNBC - Business -
DJT: Why Trump Media shares closed more than 12% higher
Trump Media, trading under the DJT ticker, has more than doubled in share price during the criminal trial of majority shareholder Donald Trump.CNBC - Business - Donald Trump -
Tesla jumps 15% after passing key hurdle to roll out advanced driver-assistance tech in China
Shares of Tesla rose sharply after the company passed a significant milestone to roll out its advanced driver-assistance technology in China.CNBC - Business - China